158 related articles for article (PubMed ID: 16553929)
21. A randomized, placebo-controlled trial of intermittent preventive treatment with sulphadoxine-pyrimethamine in Gambian multigravidae.
Mbaye A; Richardson K; Balajo B; Dunyo S; Shulman C; Milligan P; Greenwood B; Walraven G
Trop Med Int Health; 2006 Jul; 11(7):992-1002. PubMed ID: 16827700
[TBL] [Abstract][Full Text] [Related]
22. [Decision making policies on the utilization of antimalarials in response to a modification of chloroquine efficacity. Applications to Africa].
Baudon D
Med Trop (Mars); 1995; 55(4 Suppl):37-40. PubMed ID: 8649264
[TBL] [Abstract][Full Text] [Related]
23. Rapid increase in the prevalence of sulfadoxine-pyrimethamine resistance among Plasmodium falciparum isolated from pregnant women in Ghana.
Mockenhaupt FP; Bedu-Addo G; Eggelte TA; Hommerich L; Holmberg V; von Oertzen C; Bienzle U
J Infect Dis; 2008 Nov; 198(10):1545-9. PubMed ID: 18834303
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of intermittent preventive treatment versus chloroquine prophylaxis to prevent malaria during pregnancy in Benin.
Briand V; Denoeud L; Massougbodji A; Cot M
J Infect Dis; 2008 Aug; 198(4):594-601. PubMed ID: 18598190
[TBL] [Abstract][Full Text] [Related]
25. Health workers perceptions on chloroquine and sulfadoxine/sulfalene pyrimethamine monotherapies: implications for the change to combination therapy of artemether/lumefantrine in Tanzania.
Tarimo DS; Malekela DA
East Afr J Public Health; 2007 Apr; 4(1):43-6. PubMed ID: 17907761
[TBL] [Abstract][Full Text] [Related]
26. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
[TBL] [Abstract][Full Text] [Related]
27. Protecting pregnant women from malaria in areas of high HIV infection prevalence.
Meshnick SR; Mwapasa V; Rogerson SJ
J Infect Dis; 2006 Aug; 194(3):273-5. PubMed ID: 16826473
[No Abstract] [Full Text] [Related]
28. The costs of changing national policy: lessons from malaria treatment policy guidelines in Tanzania.
Mulligan JA; Mandike R; Palmer N; Williams H; Abdulla S; Bloland P; Mills A
Trop Med Int Health; 2006 Apr; 11(4):452-61. PubMed ID: 16553928
[TBL] [Abstract][Full Text] [Related]
29. Malaria in pregnancy before and after the implementation of a national IPTp program in Gabon.
Ramharter M; Schuster K; Bouyou-Akotet MK; Adegnika AA; Schmits K; Mombo-Ngoma G; Agnandji ST; Nemeth J; Afène SN; Issifou S; Onnas IN; Kombila M; Kremsner PG
Am J Trop Med Hyg; 2007 Sep; 77(3):418-22. PubMed ID: 17827353
[TBL] [Abstract][Full Text] [Related]
30. Perception and practice of malaria prophylaxis in pregnancy among health care providers in Ibadan.
Onyeaso NC; Fawole AO
Afr J Reprod Health; 2007 Aug; 11(2):69-78. PubMed ID: 20690289
[TBL] [Abstract][Full Text] [Related]
31. Lack of inhibition of the anti-malarial action of sulfadoxine-pyrimethamine by folic acid supplementation when used for intermittent preventive treatment in Gambian primigravidae.
Mbaye A; Richardson K; Balajo B; Dunyo S; Shulman C; Milligan P; Greenwood B; Walraven G
Am J Trop Med Hyg; 2006 Jun; 74(6):960-4. PubMed ID: 16760504
[TBL] [Abstract][Full Text] [Related]
32. Appraisal on the prevalence of malaria and anaemia in pregnancy and factors influencing uptake of intermittent preventive therapy with sulfadoxine-pyrimethamine in Kibaha district, Tanzania.
Tarimo SD
East Afr J Public Health; 2007 Oct; 4(2):80-3. PubMed ID: 18085136
[TBL] [Abstract][Full Text] [Related]
33. Malaria in pregnancy: challenges for control and the need for urgent action.
Menéndez C; Ferenchick E; Roman E; Bardají A; Mangiaterra V
Lancet Glob Health; 2015 Aug; 3(8):e433-e434. PubMed ID: 26187483
[No Abstract] [Full Text] [Related]
34. An analysis of country adoption and implementation of the 2012 WHO recommendations for intermittent preventive treatment for pregnant women in sub-Saharan Africa.
Henry M; Florey L; Youll S; Gutman JR
Malar J; 2018 Oct; 17(1):364. PubMed ID: 30326904
[TBL] [Abstract][Full Text] [Related]
35. A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants.
Kobbe R; Kreuzberg C; Adjei S; Thompson B; Langefeld I; Thompson PA; Abruquah HH; Kreuels B; Ayim M; Busch W; Marks F; Amoah K; Opoku E; Meyer CG; Adjei O; May J
Clin Infect Dis; 2007 Jul; 45(1):16-25. PubMed ID: 17554695
[TBL] [Abstract][Full Text] [Related]
36. A community-based delivery system of intermittent preventive treatment of malaria in pregnancy and its effect on use of essential maternity care at health units in Uganda.
Mbonye AK; Bygbjerg IC; Magnussen P
Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1088-95. PubMed ID: 17822729
[TBL] [Abstract][Full Text] [Related]
37. Intermittent preventive treatment of malaria in pregnancy: the incremental cost-effectiveness of a new delivery system in Uganda.
Mbonye AK; Hansen KS; Bygbjerg IC; Magnussen P
Trans R Soc Trop Med Hyg; 2008 Jul; 102(7):685-93. PubMed ID: 18513767
[TBL] [Abstract][Full Text] [Related]
38. Intermittent presumptive treatment in pregnancy with sulfadoxine-pyrimethamine: a counter perspective.
Nosten F; McGready R
Malar J; 2015 Jun; 14():248. PubMed ID: 26088554
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union.
Tall A; Rabarijaona LP; Robert V; Bedja SA; Ariey F; Randrianarivelojosia M
Acta Trop; 2007 Jun; 102(3):176-81. PubMed ID: 17568549
[TBL] [Abstract][Full Text] [Related]
40. Perceptions on use of sulfadoxine-pyrimethamine in pregnancy and the policy implications for malaria control in Uganda.
Mbonye AK; Neema S; Magnussen P
Health Policy; 2006 Aug; 77(3):279-89. PubMed ID: 16122831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
